Image

Pilot Study to Evaluate Targeted Physical Activity Among Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy

Trying physical activity for pancreatic cancer patients on chemotherapy.

Recruiting
18 years and older
All
Phase N/A

This study is for patients with pancreatic cancer receiving neoadjuvant chemotherapy, which is treatment before surgery to shrink tumors. Patients with this type of cancer often face functional decline and may experience more severe effects if they are frail, meaning weaker or more fragile. The study aims to test a special physical activity program to help improve strength and daily function in these patients. The exercises are low-intensity and use resistance, like lifting light weights or using stretchy bands.

Key points to consider:

  • The study involves supervised exercise sessions.
  • Participants must be at least 18 years old and able to provide consent.
  • It’s important to be medically fit for exercise, as determined by doctors.

This program aims to provide preliminary data on how safe and feasible the exercise routine is, and how it might improve participants' ability to handle daily activities. This information will help design future studies. Eligibility includes being diagnosed with pancreatic cancer, able to communicate in English or Spanish, and willing to participate in scheduled activities.

Study details
    Physiological Reactivity to Cues
    Physical Exercise

NCT07647250

University of Illinois at Chicago

6 August 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.